No association between the brain-derived neurotrophic factor 196G>A or 270C>T polymorphisms and Alzheimer's or Parkinson's disease

Folia Neuropathologica

Volumn 44, Issue 1, 2006, Pages 12-16

  Saarela, Marika S ^a,b   Lehtimäki, Terho ^a,b   Rinne, Juha O ^c   Huhtala, Heini ^d   Rontu, Riikka ^a,b   Hervonen, Antti ^d   Röyttä, Matias ^c   Ahonen, Jukka Pekka ^a   Mattila, Kari M ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Apolipoprotein E; Genotype; Polymerase chain reaction

Indexed keywords

ALANINE; APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR; CYSTEINE; DNA; GUANINE; TYROSINE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; FINLAND; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CELL; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; RISK ASSESSMENT;

EID: 33645634378     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bodner SM, Berrettini W, van Deerlin V, Bennett DA, Wilson RS, Trojanowski JQ, Arnold SE. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 1-5.
2. Combarros O, Infante J, Llorca J, Berciano J. Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 18: 55-58.
3. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. Brain derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997; 49: 71-81.
4. Desai P, Nebes R, DeKosky ST, Kamboh MI. Investigation of the effect of brain derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci Lett 2005; 379: 229-234.
5. Ferrer I, Ballabriga J, Marti E, Perez E, Alberch J, Arenas E. BDNF up regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 1998; 8: 253-261.
6. Hakansson A, Melke J, Westberg L, Shahabi HN, Buervenich S, Carmine A, Klingborg K, Grundell MB, Schulhof B, Holmberg B, Ahlberg J, Eriksson E, Sydow O, Olson L, Johnels B, Nissbrandt H. Lack of association between the BDNF Val66Met polymorphism and Parkirson's disease in a Swedish population. Ann Neurol 2003; 53: 823.
7. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548.
8. Hock C, Heese K, Hulette C, Rosenberg C, Otter U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000; 57: 846-851.
9. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000; 76: 347-354.
10. Hong CJ, Liu HC, Liu TY, Lin CH, Cheng CY, Tsai SJ. Brain derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset. Neurosci Lett 2003; 353: 75-77.
11. Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 2000; 166: 127-135.
12. Itoh K, Hashimoto K, Kumakiri C, Shimizu E, Iyo M. Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects. Am J Med Genet B Neuropsychiatr Genet 2004; 124: 61-63.
13. Kosik KS. Alzheimer's disease: a cell biological perspective. Science 1992; 256: 780-783.
14. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, Kobayashi S, Nanko S. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001; 6: 83-86.
15. Masaki T, Matsushita S, Arai H, Takeda A, Itoyama Y, Mochizuki H, Kamakura K, Ohara S, Higuchi S. Association between a polymorphism of brain derived neurotrophic factor gene and sporadic Parkinson's disease. Ann Neurol 2003; 54: 276-277.
16. Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T, Higuchi S. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm 2005; 112: 703-771.
17. McKhann C, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
18. Michalski B, Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 2003; 111: 148-154.
19. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
20. Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, Kanazawa I, Toda T. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002; 51: 133-136.
21. Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001; 63: 71-124.
22. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T, Katsu T, Tanaka Y, Hamamura T, Kuroda S. Association study of the brain derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20.
23. Olin D, MacMurray J, Comings DE. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett 2005; 381: 275-278.
24. Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raismar Vozari R. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 1999; 10: 557-561.
25. Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain derived neurotrophic factor gene with familial Parkinson's disease. Parkinsonism Relat Disord 2004; 10: 213-219.
26. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991; 7: 695-702.
27. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Muller U, Forstl H, Kurz A. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 2002; 7: 782-785.
28. Rocchi A, Peilegrini S, Siciliano G, Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 2003; 61: 1-24.
29. Toda T, Momose Y, Murata M, Tamiya G, Yamamoto M, Hattori N, Inoko H. Toward identification of susceptibility genes for sporadic Parkinson's disease. J Neurol 2003; 250 Suppl 3: III40-43.
30. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, Gennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002; 7: 136-137.
31. Vepsalainen S, Castren E, Helisalmi S, Iivonen S, Mannermaa A, Lehtovirta M, Hanninen T, Soininen H, Hiltunen M. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol 2005; 252: 423-428.